168 related articles for article (PubMed ID: 37178426)
1. Molecular cluster mining of high-grade serous ovarian cancer via multi-omics data analysis aids precise medicine.
Cai D; Liu T; Fang J; Liu Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9151-9165. PubMed ID: 37178426
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics cluster defines the subtypes of CRC with distinct prognosis and tumor microenvironment.
Ma Y; Li J; Zhao X; Ji C; Hu W; Ma Y; Qu F; Sun Y; Zhang X
Eur J Med Res; 2024 Mar; 29(1):207. PubMed ID: 38549156
[TBL] [Abstract][Full Text] [Related]
3. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
[TBL] [Abstract][Full Text] [Related]
4. Multi-Omics Integrative Analysis of Lung Adenocarcinoma: An
Ruan X; Ye Y; Cheng W; Xu L; Huang M; Chen Y; Zhu J; Lu X; Yan F
Front Med (Lausanne); 2022; 9():894338. PubMed ID: 35721082
[TBL] [Abstract][Full Text] [Related]
5. Immune depletion of the methylated phenotype of colon cancer is closely related to resistance to immune checkpoint inhibitors.
Zhong C; Xie T; Chen L; Zhong X; Li X; Cai X; Chen K; Lan S
Front Immunol; 2022; 13():983636. PubMed ID: 36159794
[TBL] [Abstract][Full Text] [Related]
6. MMDAE-HGSOC: A novel method for high-grade serous ovarian cancer molecular subtypes classification based on multi-modal deep autoencoder.
Wang HQ; Li HL; Han JL; Feng ZP; Deng HX; Han X
Comput Biol Chem; 2023 Aug; 105():107906. PubMed ID: 37336028
[TBL] [Abstract][Full Text] [Related]
7. A novel subtype to predict prognosis and treatment response with DNA driver methylation-transcription in ovarian cancer.
Xu Z; Zhang L; Wang M; Huang Y; Zhang M; Li S; Wang L; Li K; Hou Y
Epigenomics; 2022 Sep; 14(18):1073-1088. PubMed ID: 36200265
[TBL] [Abstract][Full Text] [Related]
8. Molecular Cluster Mining of Adrenocortical Carcinoma via Multi-Omics Data Analysis Aids Precise Clinical Therapy.
Guan Y; Yue S; Chen Y; Pan Y; An L; Du H; Liang C
Cells; 2022 Nov; 11(23):. PubMed ID: 36497046
[TBL] [Abstract][Full Text] [Related]
9. Machine learning-based integration develops an immune-related risk model for predicting prognosis of high-grade serous ovarian cancer and providing therapeutic strategies.
Wu Q; Tian R; He X; Liu J; Ou C; Li Y; Fu X
Front Immunol; 2023; 14():1164408. PubMed ID: 37090728
[TBL] [Abstract][Full Text] [Related]
10. Molecular classification reveals the sensitivity of lung adenocarcinoma to radiotherapy and immunotherapy: multi-omics clustering based on similarity network fusion.
Zhang J; Li Y; Dai W; Tang F; Wang L; Wang Z; Li S; Ji Q; Zhang J; Liao Z; Yu J; Xu Y; Gong J; Hu J; Li J; Guo X; He F; Han L; Gong Y; Ouyang W; Wang Z; Xie C
Cancer Immunol Immunother; 2024 Mar; 73(4):71. PubMed ID: 38430394
[TBL] [Abstract][Full Text] [Related]
11. Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance.
Zheng K; Hai Y; Xi Y; Zhang Y; Liu Z; Chen W; Hu X; Zou X; Hao J
J Transl Med; 2023 Nov; 21(1):789. PubMed ID: 37936202
[TBL] [Abstract][Full Text] [Related]
12. Multi-omics-based analysis of high grade serous ovarian cancer subtypes reveals distinct molecular processes linked to patient prognosis.
Wang YA; Neff R; Song WM; Zhou X; Vatansever S; Walsh MJ; Chen SH; Zhang B
FEBS Open Bio; 2023 Apr; 13(4):617-637. PubMed ID: 36637997
[TBL] [Abstract][Full Text] [Related]
13. Mononuclear phagocyte system-related multi-omics features yield head and neck squamous cell carcinoma subtypes with distinct overall survival, drug, and immunotherapy responses.
Zhang C; Deng J; Li K; Lai G; Liu H; Zhang Y; Xie B; Zhong X
J Cancer Res Clin Oncol; 2024 Jan; 150(2):37. PubMed ID: 38279056
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment.
Zheng X; Ma Y; Bai Y; Huang T; Lv X; Deng J; Wang Z; Lian W; Tong Y; Zhang X; Yue M; Zhang Y; Li L; Peng M
Front Immunol; 2022; 13():984480. PubMed ID: 36389763
[TBL] [Abstract][Full Text] [Related]
15. Tumour microenvironment-based molecular profiling reveals ideal candidates for high-grade serous ovarian cancer immunotherapy.
Lu X; Ji C; Jiang L; Zhu Y; Zhou Y; Meng J; Gao J; Lu T; Ye J; Yan F
Cell Prolif; 2021 Mar; 54(3):e12979. PubMed ID: 33522069
[TBL] [Abstract][Full Text] [Related]
16. Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model.
Zheng K; Hai Y; Chen H; Zhang Y; Hu X; Ni K
J Transl Med; 2024 Apr; 22(1):365. PubMed ID: 38632658
[TBL] [Abstract][Full Text] [Related]
17. Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes.
Murakami R; Matsumura N; Mandai M; Yoshihara K; Tanabe H; Nakai H; Yamanoi K; Abiko K; Yoshioka Y; Hamanishi J; Yamaguchi K; Baba T; Koshiyama M; Enomoto T; Okamoto A; Murphy SK; Mori S; Mikami Y; Minamiguchi S; Konishi I
Am J Pathol; 2016 May; 186(5):1103-13. PubMed ID: 26993207
[TBL] [Abstract][Full Text] [Related]
18. Multi-omics consensus portfolio to refine the classification of lung adenocarcinoma with prognostic stratification, tumor microenvironment, and unique sensitivity to first-line therapies.
Zou Y; Cao C; Wang Y; Zhou Y; Yao S; Zhang L; Zheng K; Zhang H; Qin W; Qin K; Xiong H; Yuan X; Fu S; Wang Y; Xiong H
Transl Lung Cancer Res; 2022 Nov; 11(11):2243-2260. PubMed ID: 36519025
[TBL] [Abstract][Full Text] [Related]
19. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer.
Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y
Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma.
Wang Y; Zheng XD; Zhu GQ; Li N; Zhou CW; Yang C; Zeng MS
Front Immunol; 2022; 13():861328. PubMed ID: 35479084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
